• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neurobo Pharmaceuticals Inc (NQ: NRBO )

    2.560 UNCHANGED
    Streaming Delayed Price Updated: 3:59 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Neurobo Pharmaceuticals Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Life Sciences Investor Forum Agenda Announced for November 14th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    NeuroBo Pharmaceuticals to Present at the November 21st Virtual Investor Summit Microcap Event
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q2 2024
    NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
    Via Benzinga
    NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
    NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q1 2024
    NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    The Top 3 Stocks to Watch This Week
    There are three stocks to watch this week as they experienced significant price movements worth your attention. 
    Via InvestorPlace
    Dow Jumps 250 Points; Honeywell Issues Weak Forecast
    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Stocks Rise Amid Flood Of Economic Data
    Stocks are comfortably higher this afternoon, as investors continue to unpack the Fed's rate decision as well as this morning's jobs data. 
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
    U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&P 500 also rose,... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks
    Via Investor Brand Network
    Exposures COVID-19
    Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher
    NeuroBo announced that the FDA has cleared its IND application for DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon... 
    Via Benzinga
    Exposures Product Safety
    Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000
    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.14% to 38,204.88 while the NASDAQ... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today?
    NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares are trading lower in Friday's premarket session after ending Thursday's session with a whopping 21.2% gain. 
    Via Benzinga
    Life Science Investor Forum: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Life Science Investor Forum Agenda Announced for December 14th, 2023
    From Virtual Investor Conferences
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
    Via Benzinga
    NeuroBo Pharma Says Its Weight Loss Candidate Outperforms Major Competitors in Preclinical Obesity Study
    NeuroBo Pharmaceuticals Inc (NASDAQ: NRBO) says its DA-1726, a novel oxyntomodulin analog functioning as a glucagon-like peptide-1 receptor and glucagon receptor dual agonist, had been shown to elicit... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      Monday's session saw 41 companies set new 52-week lows. 
    Via Benzinga
    Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
    Gainers Axcella Health Inc. (NASDAQ: AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue. 
    Via Benzinga
    Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.